Post-Grant for Practitioners: BioPharma Patents at the PTAB
In 2017, 239 IPR petitions relating to biopharma patents were filed-making it the most active year for this technology center. In “BioPharma Patents at the PTAB,” Fish’s Dorothy Whelan and Tasha Francis provide an update on biopharma patents at the PTAB. In it, they discuss PTAB statistics, recent decisions, and the implications of these decisions on the industry and the future impact on biopharma patents.
For a summary of the information presented in this webinar, please see our articles “Orange Book Patent Challenges at the PTAB” and “Establishing Drug Labels as Printed Publications.”